Literature DB >> 9769021

Production and characterization of fusion proteins containing transferrin and nerve growth factor.

E Park1, R M Starzyk, J P McGrath, T Lee, J George, A J Schutz, P Lynch, S D Putney.   

Abstract

To explore the ability to use genetic fusions of transferrin as a carrier for brain targeting and delivery, a series of fusion proteins containing both human nerve growth factor (NGF) and human transferrin was produced in mammalian cells. A protein in which the hinge region from human IgG3 joined the carboxyl terminus of NGF and the amino terminus of transferrin formed a covalent homodimer, bound human transferrin receptor, and retained full NGF in PC12 cells. In contrast, proteins in which polypeptide dimerization was not induced or in which NGF was fused through its amino terminus had greatly reduced NGF activity. The ability to maintain both biologically active NGF and transferrin as part of a fusion protein may offer a novel way to deliver NGF and other neurotrophic factors to the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9769021     DOI: 10.3109/10611869808997881

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  2 in total

1.  Novel nanocomposites from spider silk-silica fusion (chimeric) proteins.

Authors:  Cheryl Wong Po Foo; Siddharth V Patwardhan; David J Belton; Brandon Kitchel; Daphne Anastasiades; Jia Huang; Rajesh R Naik; Carole C Perry; David L Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-12       Impact factor: 11.205

2.  Insertion of the designed helical linker led to increased expression of tf-based fusion proteins.

Authors:  Nurmamet Amet; Hsin-Fang Lee; Wei-Chiang Shen
Journal:  Pharm Res       Date:  2008-11-11       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.